Optune Lua creates tumor treating fields to disrupt cancer cell division, and it is used in conjunction with PD-1/PD-L1 ...

Columnist Caroline Gainer is concerned about a couple of results from her recent annual wellness visit that could suggest ...

The American College of Radiology advises women who are at average risk for breast cancer to get mammograms annually starting ...

Novocure received a long-sought FDA approval for the use of its Tumor Treating Fields technology against metastatic non-small ...

Following promising results from the phase 3 LUNAR trial, the FDA has approved Optune Lua for use with PD-1/PD-L1 inhibitors ...

Breast cancer is the leading cause of death in women in the United States. 2. Breast cancer is the leading cause of cancer ...

The FDA yesterday the approval of Novocure’s Optune device to include the treatment of metastatic non-small cell lung cancer.

Shares of Jazz Pharmaceuticals are trading only slightly higher in the last few weeks despite two unexpected wins. Explore ...

Graves disease and cancer were associated with each other, as Graves disease diagnosis was linked to increased risks for ovarian and prostate cancers.

A mom who raised over $1 million to help support her young son and daughter after a terminal cancer diagnosis has died at the ...

Novocure Ltd (NASDAQ:NVCR) shares soared sharply after the announcement that the FDA had approved Optune Lua, a wearable ...

Current and past smokers are being offered lung checks as part of an NHS programme to catch cancer early. Invites are being sent to more than 10,000 people in Scunthorpe, aged between 55 and 74, as ...